295 related articles for article (PubMed ID: 27197162)
21. Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme.
Charalambous C; Chen TC; Hofman FM
Neurosurg Focus; 2006 Apr; 20(4):E22. PubMed ID: 16709028
[TBL] [Abstract][Full Text] [Related]
22. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
23. S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice.
Du W; Takuwa N; Yoshioka K; Okamoto Y; Gonda K; Sugihara K; Fukamizu A; Asano M; Takuwa Y
Cancer Res; 2010 Jan; 70(2):772-81. PubMed ID: 20068174
[TBL] [Abstract][Full Text] [Related]
24. Antiangiogenic Therapy Induces Hepatic Tumor Vascular Network Rearrangement to Receive Perfusion via the Portal Vein and Hepatic Artery.
Kang W; Lim JS; Park MS; Koh GY; Kim H
J Vasc Res; 2016; 53(1-2):72-82. PubMed ID: 27643516
[TBL] [Abstract][Full Text] [Related]
25. Loss of stromal JUNB does not affect tumor growth and angiogenesis.
Braun J; Strittmatter K; Nübel T; Komljenovic D; Sator-Schmitt M; Bäuerle T; Angel P; Schorpp-Kistner M
Int J Cancer; 2014 Mar; 134(6):1511-6. PubMed ID: 24027048
[TBL] [Abstract][Full Text] [Related]
26. Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth.
Lamagna C; Hodivala-Dilke KM; Imhof BA; Aurrand-Lions M
Cancer Res; 2005 Jul; 65(13):5703-10. PubMed ID: 15994945
[TBL] [Abstract][Full Text] [Related]
27. Imaging tumor angiogenesis.
Red-Horse K; Ferrara N
J Clin Invest; 2006 Oct; 116(10):2585-7. PubMed ID: 17016553
[TBL] [Abstract][Full Text] [Related]
28. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
[TBL] [Abstract][Full Text] [Related]
29. Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism.
Bix G; Castello R; Burrows M; Zoeller JJ; Weech M; Iozzo RA; Cardi C; Thakur ML; Barker CA; Camphausen K; Iozzo RV
J Natl Cancer Inst; 2006 Nov; 98(22):1634-46. PubMed ID: 17105986
[TBL] [Abstract][Full Text] [Related]
30. Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.
Rogers MS; Christensen KA; Birsner AE; Short SM; Wigelsworth DJ; Collier RJ; D'Amato RJ
Cancer Res; 2007 Oct; 67(20):9980-5. PubMed ID: 17942931
[TBL] [Abstract][Full Text] [Related]
31. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
32. Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice.
Agrawal V; Maharjan S; Kim K; Kim NJ; Son J; Lee K; Choi HJ; Rho SS; Ahn S; Won MH; Ha SJ; Koh GY; Kim YM; Suh YG; Kwon YG
Oncotarget; 2014 May; 5(9):2761-77. PubMed ID: 24811731
[TBL] [Abstract][Full Text] [Related]
33. Intermedin Enlarges the Vascular Lumen by Inducing the Quiescent Endothelial Cell Proliferation.
Wang LJ; Xiao F; Kong LM; Wang DN; Li HY; Wei YG; Tan C; Zhao H; Zhang T; Cao GQ; Zhang K; Wei YQ; Yang HS; Zhang W
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):398-413. PubMed ID: 29242270
[TBL] [Abstract][Full Text] [Related]
34. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
[TBL] [Abstract][Full Text] [Related]
35. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
36. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells.
Xiong YQ; Sun HC; Zhang W; Zhu XD; Zhuang PY; Zhang JB; Wang L; Wu WZ; Qin LX; Tang ZY
Clin Cancer Res; 2009 Aug; 15(15):4838-46. PubMed ID: 19638466
[TBL] [Abstract][Full Text] [Related]
37. Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells.
Miyazaki T; Taketomi Y; Saito Y; Hosono T; Lei XF; Kim-Kaneyama JR; Arata S; Takahashi H; Murakami M; Miyazaki A
Circ Res; 2015 Mar; 116(7):1170-81. PubMed ID: 25648699
[TBL] [Abstract][Full Text] [Related]
38. A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of Ras.
Desroches-Castan A; Quélard D; Demeunynck M; Constant JF; Dong C; Keramidas M; Coll JL; Barette C; Lafanechère L; Feige JJ
Oncotarget; 2015 Mar; 6(7):5382-411. PubMed ID: 25742784
[TBL] [Abstract][Full Text] [Related]
39. Endothelial cell development, vasculogenesis, angiogenesis, and tumor neovascularization: an update.
Tang DG; Conti CJ
Semin Thromb Hemost; 2004 Feb; 30(1):109-17. PubMed ID: 15034802
[TBL] [Abstract][Full Text] [Related]
40. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
